Factors influencing the selection of hydrocodone and oxycodone as primary opioids in substance abusers seeking treatment in the United States

Pain

Volumn 154, Issue 12, 2013, Pages 2639-2648

  Cicero, Theodore J ^a   Ellis, Matthew S ^a   Surratt, Hilary L ^b   Kurtz, Steven P ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Hydrocodone; Opioid analgesic abuse; Oxycodone; Pain management and opioid abuse

Indexed keywords

HYDROCODONE; OPIATE; OXYCODONE; PARACETAMOL;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG CHOICE; DRUG USE; EUPHORIA; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBSTANCE ABUSE; UNITED STATES;

HYDROCODONE; OPIOID ANALGESIC ABUSE; OXYCODONE; PAIN MANAGEMENT AND OPIOID ABUSE;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; CHEMISTRY, PHARMACEUTICAL; DATA COLLECTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCODONE; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; OXYCODONE; SUBSTANCE ABUSE TREATMENT CENTERS; UNITED STATES; YOUNG ADULT;

EID: 84889044823     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2013.07.025     Document Type: Article

References (46)

1. Federal Criminal Code and Rules as amended to January 21, 2005. Title 21, Chapter 13. Drug Abuse Prevention and Control 2005 Thomson West Publisher Eagan, MN [21 U.S.C. 811(C)]
2. S. Butler, S. Budman, A. Licari, T.A. Cassidy, K. Lioy, J. Dickinson, J.S. Brownstein, J.C. Benneyan, T.C. Green, and N. Katz National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product specific, public health surveillance system for monitoring prescription drug abuse Pharmacoepidemiol Drug Saf 17 2008 1142 1154
3. S. Butler, K. Fernandez, A. Chang, C. Benoit, L.C. Morey, R. Black, and N. Katz Measuring attractiveness for abuse of prescription opioids Pain Med 11 2010 67 80
4. R. Cai, E. Crane, K. Poneleit, and L. Paulozzi Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004-2008 J Pain Palliat Care Pharmacother 24 2010 293 297
5. L.P. Carter, and R.R. Griffiths Principles of laboratory assessment of drug abuse liability and implications for clinical development Drug Alcohol Depend 105 2009 S14 25
6. Center on Addiction and Substance Abuse at Columbia University (CASAColumbia) Under the counter: the diversion and abuse of controlled prescription drugs in the U.S 2005 CASAColumbia USA, New York
7. Centers for Disease Control and Prevention (CDC) Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004-2008 MMWR Morb Mortal Wkly Rep 59 2010 705 709
8. T.J. Cicero, R.C. Dart, J.A. Indiardi, G.E. Woody, S. Schnoll, and A. Munoz The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS) Pain Med 8 2007 157 170
9. T. Cicero, M. Ellis, A. Paradis, and Z. Ortbal Determinants of fentanyl and other potent mu opioid agonist misuse in opioid-dependent individuals Pharmacoepidemiol Drug Saf 19 2010 1057 1063
10. T. Cicero, M. Ellis, A. Paradis, and Z. Ortbal Role of key informants and direct patient interviews in epidemiological studies of substance abuse Pharmacoepidemiol Drug Saf 20 2011 308 312
11. T. Cicero, M. Ellis, and H.L. Surrat Effect of abuse-deterrent formulation of OxyContin N Engl J Med 367 2012 187 189
12. T.J. Cicero, J.A. Inciardi, and A. Munoz Trends in the abuse of OxyContin and other opioid analgesics in the United States: 2002-2004 J Pain 6 2005 662 672
13. T.J. Cicero, H. Surrat, J.A. Inciardi, and A. Munoz Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban and urban locations in the United States Pharmacoepidemiol Drug Saf 16 2007 827 840
14. T.J. Cicero, H.L. Surratt, S. Kurtz, M.S. Ellis, and J.A. Inciardi Patterns of prescription opioid abuse and comorbidity in an aging treatment population J Subst Abuse Treat 42 2012 87 94
15. S.D. Comer, J.B. Ashworth, R.W. Foltin, C.E. Johnason, J.P. Zacny, and S.L. Walsh The role of human drug self-administration procedures in the development of medications Drug Alcohol Depend 96 2008 1 5
16. S.D. Comer, J.P. Zacny, R.H. Dworkin, D.C. Turk, G.E. Bigelow, R.W. Foltin, D.R. Jasinski, E.M. Sellers, E.H. Adams, R. Balster, L.B. Burke, I. Cerny, R.D. Colucci, E. Cone, P. Cowan, J.T. Farrar, J.D. Haddox, J.A. Haythornthwaite, S. Hertz, G.W. Jay, C.E. Johanson, R. Junor, N.P. Katz, M. Klein, E.A. Kopecky, D.B. Leiderman, M.P. McDermott, C. O'Brien, A.B. O'Connor, P.P. Palmer, S.N. Raja, B.A. Rappaport, C. Rauschkolb, M.C. Rowbotham, C. Sampaio, B. Setnik, M. Sokolowska, J.W. Stauffer, and S.L. Walsh Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations PAIN® 153 2012 2315 2324
17. W.M. Compton, and N.D. Volkow Major increases in opioid analgesic abuse in the United States: concerns and strategies Drug Alcohol Depend 81 2006 103 107
18. M.J. Houston, and S. Sudman A methodological assessment of the use of key informants Soc Sci Res 4 1975 151 164
19. IMS Institute for Health Informatics The use of medicines in the United States: review of 2011 2012 IMS Institute for Health Informatics Parsippany, NJ
20. J.A. Inciardi, H.L. Surratt, Y. Stivers, and T.J. Cicero FDA approvals of generic drugs: impact on the diversion of opioid analgesics with a potential for abuse J Opioid Manag 5 2009 81 87
21. L.D. Johnston, P.M. O'Malley, J.G. Bachman, and J.E. Schulenberg Monitoring the future: national results on adolescent drug use, overview of key findings 2006 2007 National Institute on Drug Abuse Bethesda, MD
22. R.S. Krannich, and C.R. Humphrey Using key informant data in comparative community research: an empirical assessment Sociol Methods Res 14 1986 473 493
23. L. Manchikanti, B. Fellows, H. Ailinani, and V. Pampati Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective Pain Physician 13 2010 401 435
24. L. Manchikanti, S. Helm 2nd, B. Fellows, J.W. Janata, V. Pampati, J.S. Grider, and M.V. Boswell Opioid epidemic in the United States Pain Physician 15 2012 ES9 38
25. R.S. Mansbach, D.E. Feltner, L.H. Gold, and S.H. Schnoll Incorporating the assessment of abuse liability into the drug discovery and development process Drug Alcohol Depend 70 2003 S73 85
26. S.E. McCabe, J.A. Cranford, and B.T. West Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys Addict Behav 33 2008 1297 1305
27. J. Mendelson, K. Flower, M.J. Pletcher, and G.P. Galloway Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine Exp Clin Psychopharmacol 16 2008 435 441
28. C. Ruetsch Empirical view of opioid dependence J Manag Care Pharm 16 2010 S9 13
29. F.L. Sapienza Abuse deterrent formulations and the controlled substances act (CSA) Drug Alcohol Depend 83 2006 S23 30
30. J.D. Schulden, Y.F. Thomas, and W.M. Compton Substance abuse in the United States: findings from recent epidemiologic studies Curr Psychiatry Rep 11 2009 353 359
31. J. Seidler On using informants: a technique for collecting quantitative data and controlling measurement error in organizational analysis Am Sociol Rev 39 1974 816 831
32. H. Spiller, J.E. Bailey, R.C. Dart, and S.S. Spiller Investigation of temporal changes of abuse and misuse of prescription opioids J Addict Dis 29 2010 78 83
33. B. Sproule, B. Brands, S. Li, and L. Catz-Biro Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids Can Fam Physician 55 2009 68 69 69.e1-5
34. W.W. Stoops, K.W. Hatton, M.R. Lofwall, P.A. Nuzzo, and S.L. Walsh Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies Psychopharmacology (Berl) 212 2010 193 203
35. Substance Abuse and Mental Health Services Administration (SAMHSA). Drug Abuse Warning Network, 2010: national estimates of drug-related emergency department visits, Available from: < http://www.samhsa.gov/data/2k13/ DAWN2k10ED/DAWN2k10ED.htm#Tab18 >; 2012. [accessed 22.03.13].
36. Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey of Substance Abuse Treatment Services (N-SSATS). 2011 state profile, Available from: < http://wwwdasis.samhsa.gov/webt/state-data/US11. pdf > [accessed 22.03.13].
37. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2010 National Survey on Drug Use and Health: summary of national findings 2011 Substance Abuse and Mental Health Services Administration Rockville, MD
38. Substance Abuse and Mental Health Services Administration (SAMHSA). Treatment Episode Data Set - Admissions (TEDS-A), Available from: < http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/33261?permit%5B0%5D= AVAILABLE&q=Treatment+Episode+Data+Set+2010 >; 2010 [accessed 22.03.13].
39. M. Tremblay The key informant technique: a nonethnographic application Am Anthropol 59 1957 688 699
40. S.L. Walsh, P.A. Nuzzo, M.R. Lofwall, and J.R. Holtman Jr The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers Drug Alcohol Depend 98 2008 191 202
41. R. Wightman, J. Perrone, I. Portelli, and L. Nelson Likeability and abuse liability of commonly prescribed opioids J Med Toxicol 8 2012 335 340
42. B.L. Wilsey, S. Fishman, C.-S. Li, J. Storment, and A. Albanese Markers of abuse liability of short- vs long acting opioids in chronic pain patients: a randomized cross-over trial Pharmacol Biochem Behav 94 2009 98 107
43. L.T. Wu, D.J. Pilowsky, and A.A. Patkar Non-prescribed use of pain relievers among adolescents in the United States Drug Alcohol Depend 94 2008 1 11
44. A.M. Young, N. Glover, and J.R. Havens Nonmedical use of prescription medications among adolescents in the United States: a systematic review J Adolesc Health 51 2012 6 17
45. J. Zacny, G. Bigelow, P. Compton, K. Foley, M. Iguchi, and C. Sannerud College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement Drug Alcohol Depend 69 2003 215 232
46. J.P. Zacny, and S. Gutierrez Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers Drug Alcohol Depend 101 2009 107 114